RankingsPricing
  1. US-listed companies
  2. USANA HEALTH SCIENCES INC

USANA HEALTH SCIENCES INCUSNA

Market cap
$773.08M
P/E ratio
12.1x
Back to summarized table
Income statementBalance sheetCash flow
Dec 31,
2011		Dec 29,
2012		Dec 28,
2013		Jan 3,
2015		Jan 2,
2016		Dec 31,
2016		Dec 30,
2017		Dec 29,
2018		Dec 28,
2019		Jan 2,
2021		Jan 1,
2022		Dec 31,
2022		Dec 30,
2023
Net earnings5166797795100631261011251176964
Depreciation and amortization8999101316--14131313
Right-of-use asset amortization----------988
(Gain) loss on sale of property and equipment-000-0-0-0-0---0-0-0-0
Equity-based compensation expense1110810111715--14141315
Deferred income taxes----------2-3-7-3
Other Asset Impairment Charges------3--1---
Inventory write-down------------3
Inventories3-112-1231-6--1711-22-2
Prepaid expenses and other assets-4684210-5--7523-0
Accounts payable2-13-12-13--6-5-3-0
Other liabilities-01327152123-7--16-11-9-30
Net cash provided by (used in) operating activities709399105--124--16012110471
Depreciation and amortization8999101316--14131313
Right-of-use asset amortization----------988
(Gain) loss on sale of property and equipment-000-0-0-0-0---0-0-0-0
Equity-based compensation expense1110810111715--14141315
Deferred income taxes----------2-3-7-3
Other Asset Impairment Charges------3--1---
Inventory write-down------------3
Inventories3-112-1231-6--1711-22-2
Prepaid expenses and other assets-4684210-5--7523-0
Accounts payable2-13-12-13--6-5-3-0
Other liabilities-01327152123-7--16-11-9-30
Net cash provided by (used in) operating activities709399105--124--16012110471
Receipts on notes receivable-----10--00--
Proceeds from Hedge, Investing Activities---------2-54
Payments for net investment hedge---------12-1
Payments for investment in equity securities---------20---
Payments to acquire businesses-----------7-
Proceeds from sale of property and equipment0000000--0000
Proceeds from sale of property and equipment0000000--0000
Purchases of property and equipment118820243313--15131014
Purchases of property and equipment118820243313--15131014
Net cash provided by (used in) investing activities-11-8-22-16---13---34-14-12-12
Net cash provided by (used in) investing activities-11-8-22-16---13---34-14-12-12
Repurchase of common stock336818139616550--571782512
Borrowings on line of credit-2-30-744--60-112
Payments on line of credit-2-30-744--60-111
Payments related to tax withholding for net-share settled equity awards------0--2453
Payments for debt issuance costs-----0---0---
Payments for contingent consideration------------0
Net cash provided by (used in) financing activities-33-65-10-113---50---59-181-30-14
Effect of exchange rate changes on cash, cash equivalents, and restricted cash---------112-14-3
Net increase (decrease) in cash, cash equivalents, and restricted cash---------78-724842
Interest0000000--1000
Income taxes25272727365346--53604644
Income tax refund------5--1002
Right-of-use assets obtained in exchange for lease obligations-----------66
Accrued purchases of property and equipment---------0010
Accrued purchases of property and equipment---------0010
Contingent consideration given to acquire businesses-----------1-
Excise and Sales Taxes------------0
Contingent consideration given to acquire businesses-----------1-
Net earnings5166797795100631261011251176964
Depreciation and amortization8999101316--14131313
Right-of-use asset amortization----------988
(Gain) loss on sale of property and equipment-000-0-0-0-0---0-0-0-0
Equity-based compensation expense1110810111715--14141315
Deferred income taxes----------2-3-7-3
Other Asset Impairment Charges------3--1---
Inventory write-down------------3
Inventories3-112-1231-6--1711-22-2
Prepaid expenses and other assets-4684210-5--7523-0
Accounts payable2-13-12-13--6-5-3-0
Other liabilities-01327152123-7--16-11-9-30
Net cash provided by (used in) operating activities709399105--124--16012110471
Receipts on notes receivable-----10--00--
Proceeds from Hedge, Investing Activities---------2-54
Payments for net investment hedge---------12-1
Payments for investment in equity securities---------20---
Payments to acquire businesses-----------7-
Proceeds from sale of property and equipment0000000--0000
Proceeds from sale of property and equipment0000000--0000
Purchases of property and equipment118820243313--15131014
Purchases of property and equipment118820243313--15131014
Net cash provided by (used in) investing activities-11-8-22-16---13---34-14-12-12
Net cash provided by (used in) investing activities-11-8-22-16---13---34-14-12-12
Repurchase of common stock336818139616550--571782512
Borrowings on line of credit-2-30-744--60-112
Payments on line of credit-2-30-744--60-111
Payments related to tax withholding for net-share settled equity awards------0--2453
Payments for debt issuance costs-----0---0---
Payments for contingent consideration------------0
Net cash provided by (used in) financing activities-33-65-10-113---50---59-181-30-14
Effect of exchange rate changes on cash, cash equivalents, and restricted cash---------112-14-3
Net increase (decrease) in cash, cash equivalents, and restricted cash---------78-724842
Interest0000000--1000
Income taxes25272727365346--53604644
Income tax refund------5--1002
Right-of-use assets obtained in exchange for lease obligations-----------66
Accrued purchases of property and equipment---------0010
Accrued purchases of property and equipment---------0010
Contingent consideration given to acquire businesses-----------1-
Excise and Sales Taxes------------0